QUESTCOR PHARMACEUTICALS INC Revenue
QUESTCOR PHARMACEUTICALS INC reported Revenue of $278.83 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-07-25.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2014-07-25
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $278.83M, a 51.07% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $227.10M, a 68.06% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $242.88M, a 51.30% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $236.35M, a 68.41% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for fiscal 2013 was $798.93M, a 56.87% increase from fiscal 2012.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for fiscal 2012 was $509.29M, a 133.44% increase from fiscal 2011.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for fiscal 2011 was $218.17M, a 89.50% increase from fiscal 2010.
- QUESTCOR PHARMACEUTICALS INC revenue, net (deprecated 2018-01-31) for fiscal 2010 was $115.13M, a 30.36% increase from fiscal 2009.
| Period end | Revenue, Net (Deprecated 2018-01-31) 2 month | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | $278.83M 10-Q · filed 2014-07-25 | $505.93M 10-Q · filed 2014-07-25 | $748.82M derived: sum of 3 quarters · filed 2014-07-25 | $985.16M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2014-03-31 | $227.10M 10-Q · filed 2014-04-29 | $469.99M derived: sum of 2 quarters · filed 2014-04-29 | $706.33M derived: sum of 3 quarters · filed 2014-04-29 | $890.90M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-12-31 | $242.88M 10-K · filed 2014-02-26 | $479.23M derived: sum of 2 quarters · filed 2014-02-26 | $663.80M derived: sum of 3 quarters · filed 2014-07-25 | $798.93M 10-K · filed 2014-02-26 | |
| 2013-09-30 | $236.35M 10-K · filed 2014-02-26 | $420.92M derived: sum of 2 quarters · filed 2014-07-25 | $556.05M 10-Q · filed 2013-10-30 | $716.58M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-06-30 | $184.57M 10-Q · filed 2014-07-25 | $319.70M 10-Q · filed 2014-07-25 | $480.24M derived: sum of 3 quarters · filed 2014-07-25 | $620.57M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-03-31 | $135.13M 10-Q · filed 2014-04-29 | $295.66M derived: sum of 2 quarters · filed 2014-04-29 | $436.00M derived: sum of 3 quarters · filed 2014-04-29 | $548.45M derived: sum of 4 quarters · filed 2014-04-29 | |
| 2012-12-31 | $160.53M 10-K · filed 2014-02-26 | $300.87M derived: sum of 2 quarters · filed 2014-02-26 | $413.32M derived: sum of 3 quarters · filed 2014-02-26 | $509.29M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $140.34M 10-K · filed 2014-02-26 | $252.79M derived: sum of 2 quarters · filed 2014-02-26 | $348.76M 10-Q · filed 2013-10-30 | $424.29M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-09-01 | $140.34M 10-Q · filed 2012-10-23 | ||||
| 2012-06-30 | $112.45M 10-K · filed 2014-02-26 | $208.42M 10-Q · filed 2013-07-31 | $283.95M derived: sum of 3 quarters · filed 2014-02-26 | $343.78M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | $95.97M 10-K · filed 2014-02-26 | $171.50M derived: sum of 2 quarters · filed 2014-02-26 | $231.32M derived: sum of 3 quarters · filed 2014-02-26 | $277.30M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | $75.53M 10-K · filed 2013-02-27 | $135.36M derived: sum of 2 quarters · filed 2013-02-27 | $181.34M derived: sum of 3 quarters · filed 2013-02-27 | $218.17M 10-K · filed 2014-02-26 | |
| 2011-09-30 | $59.82M 10-K · filed 2013-02-27 | $105.80M derived: sum of 2 quarters · filed 2013-02-27 | $142.63M 10-Q/A · filed 2012-10-25 | $171.93M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-09-01 | $59.82M 10-Q · filed 2012-10-23 | ||||
| 2011-06-30 | $45.98M 10-K · filed 2013-02-27 | $82.81M 10-Q · filed 2012-07-25 | $112.11M derived: sum of 3 quarters · filed 2013-02-27 | $143.38M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-31 | $36.83M 10-K · filed 2013-02-27 | $66.13M derived: sum of 2 quarters · filed 2013-02-27 | $97.40M derived: sum of 3 quarters · filed 2013-02-27 | $125.72M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-31 | $29.30M 10-K/A · filed 2012-03-19 | $60.57M derived: sum of 2 quarters · filed 2012-03-19 | $88.89M derived: sum of 3 quarters · filed 2012-03-19 | $115.13M 10-K · filed 2013-02-27 | |
| 2010-09-30 | $31.27M 10-K/A · filed 2012-03-19 | $59.59M derived: sum of 2 quarters · filed 2012-03-19 | $85.83M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $28.32M 10-K/A · filed 2012-03-19 | $54.56M 10-Q · filed 2011-07-29 | |||
| 2010-03-31 | $26.24M 10-K/A · filed 2012-03-19 | ||||
| 2009-12-31 | $88.32M 10-K/A · filed 2012-03-19 |